Erlocip contains erlotinib and belongs to a class of medications called kinase inhibitors.
Erlocip is used for the treatment of non-small cell lung cancer.
Erlocip is used in combination with gemcitabine for the treatment of pancreatic cancer that has spread to nearby tissues or to other parts of the body..
MECHANISM OF ACTION
Erlocip works by blocking the action of an abnormal protein that slows the growth of cancer c ells. This helps slow or stop the spread of cancer cells.
Erlocip is available as 150mg tablets.
Symptoms of overdose associated with Erlocip may include diarrhea and rash.
This is custom tab. You can add custom tab as an attribute for entire products, or for each categories. You can add CMS content such as sizing guide or videos to enhance product detail.